AzTrials
AzTrials

Lyme DiseaseADO-LYNCT05678478

Perceptions,Social Representations and Experience of Lyme Borreliosis and Ticks in Adolescents Likely to be Infected and Their Parents

An observational study of Lyme Disease, run by Centre Hospitalier Intercommunal Creteil at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

the study is offered to adolescents aged 12 to 17 and their families suspected of or suffering from Lyme barilliosis. During inclusion, three interviews will be carried out for each family. Read more about this study

Who is it for?
Ages 12 to 17 years
Conditions the study is for
Lyme Disease
What is being tested?
semi-directed interview concerning the experience of adolescents and their parents on Lyme borreliosis and on the tick.
How many people
5 participants
Where
2 sitesFrance
Study dates
1 Feb 2023to 20 Jun 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 17 years
  • All sexes
  • Child

Study population: These are patients aged 12 to 17 years maximum and their parents come for a suspicion of adolescent Lyme borreliosis.

Who may be able to join

  • Be at least 12 years old and maximum 17 years old.
  • Be accompanied by a holder of parental authority
  • Live in metropolitan France.
  • Suspect or have Lyme borreliosis
  • Non-objection for participation in the protocol

Who cannot join

  • Refusal of participation of a holder of parental authority and of the adolescent
  • Non-mastery of oral French by the teenager or his parents
  • Protected persons (patients under guardianship or curatorship, pregnant or nursing women, persons deprived of liberty, person unable to express their non-objection)

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Centre Hospitalier Intercommunal Villeneuve Saint Georges

    Crosne, 91560

  • Hôpital Armand Trousseau AP-HP

    Paris, 75012

Other trials in France

About this study

the study is offered to adolescents aged 12 to 17 and their families suspected of or suffering from Lyme barilliosis.

During inclusion, three interviews will be carried out for each family. This choice of the number of interviews per family seems the most appropriate to have a plurality of answers to the questions asked. Thus, these will have a duration of 30 min to 1 hour and will be carried out by an anthropologist. The first interview will be with the teenager. The second interview will then concern the parent(s). Finally, the last appointment will be with the teenager and his parents.

Read the detailed description

the study is offered to adolescents aged 12 to 17 and their families suspected of or suffering from Lyme barilliosis.

During inclusion, three interviews will be carried out for each family. This choice of the number of interviews per family seems the most appropriate to have a plurality of answers to the questions asked. Thus, these will have a duration of 30 min to 1 hour and will be carried out by an anthropologist. The first interview will be with the teenager. The second interview will then concern the parent(s). Finally, the last appointment will be with the teenager and his parents.

After a few introductory questions concerning the socio-demographic characteristics of adolescents, their medical history and their exposure to ticks, the anthropologist will ask the semi-open questions.

As for the parent(s), the anthropologist will ask them questions directly related to Lyme borreliosis and the tick. Finally, questions will be proposed simultaneously during a joint interview with the teenager and his parents.

Conditions
Lyme Disease
Being tested
semi-directed interview concerning the experience of adolescents and their parents on Lyme borreliosis and on the tick.
Medical subject headings
Lyme Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • semi-directed interview concerning the experience of adolescents and their parents on Lyme borreliosis and on the tick.Other

    semi-structured interview on the experience of adolescents and their parents on Lyme borreliosis and the tick.

    The interviews will be semi-directed in physical presence. Three interviews will be conducted.

    The minor will be questioned first, then the parent(s). And finally, the whole family in one interview. All interviews will be audio recorded with parallel note taking in order to best transcribe the visual expressions. The interviews will be transcribed in writing and pseudonymised.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Story of the teenager and one of his parents or both parents

    analysis and identification of perceptions, representations and experiences of adolescents and their parents on Lyme borreliosis and ticks

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2023
  2. Study start1 Feb 2023
  3. Primary completion20 Jun 2023
  4. Study completion20 Jun 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
5 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05678478
Sponsor's protocol ID
ADO-LY
Acronym
ADO-LY
Status last verified
Jul 2024
First submitted
23 Dec 2022
Last updated
24 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Covasso S, Paoletti G, Lorrot M, Dugue S, Cardin S, Puppo C, Chosidow A, Raffetin A. Perceptions, social representations, and experiences of suspected Lyme borreliosis among adolescents and their parents in France: A multicenter study. PLoS One. 2026 Sep 21;21(9):e0357185. doi: 10.1371/journal.pone.0357185. eCollection 2026.

    PubMed 42766572

Questions about this trial

What is this clinical trial studying?

An observational study of Lyme Disease, run by Centre Hospitalier Intercommunal Creteil at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Story of the teenager and one of his parents or both parents (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05678478, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in